These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 26105511

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ, Watt HC.
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG.
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Nov 10; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM, Swanston IA, McNeilly AS, Ashby JP, Blundell G, Calder AA, Groome NP.
    Clin Endocrinol (Oxf); 1996 Jan 10; 44(1):17-21. PubMed ID: 8706288
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trial.
    Spencer K, Macri JN, Anderson RW, Aitken DA, Berry E, Crossley JA, Wood PJ, Coombes EJ, Stroud M, Worthington DJ.
    Ann Clin Biochem; 1993 Jul 10; 30 ( Pt 4)():394-401. PubMed ID: 7691041
    [Abstract] [Full Text] [Related]

  • 19. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr 10; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 20. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G, Goldman B, Ries L, Chaki R, Cuckle H.
    Prenat Diagn; 1996 Apr 10; 16(4):319-22. PubMed ID: 8734805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.